Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTEN

Overview of attention for article published in Journal of Hematology & Oncology, March 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 361 followers.

TRAF3IP2-AS1 expression has the potential to serve as a novel diagnostic and prognostic biomarker for NONO-TFE3 tRCC detection.

#JHematolOncol: TRAF3IP2-AS1 functions as a #tumor #suppressor in NONO-TFE3 tRCC progression and may serve as a novel target for NONO-TFE3 tRCC therapy. α-Amanitin was from #MedChemExpress. https://t.co/yh49txKe0M

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.